07/08/2025
PMCC Delegation Visits CIC, UMMC Amid Efforts to Develop Phase I Unit
7 May 2025 | Kuala Lumpur
The Clinical Investigation Centre (CIC), UMMC was honored to host a delegation from Princess Margaret Cancer Centre (PMCC), Canada in a visit facilitated by Clinical Research Malaysia (CRM).
This timely engagement comes as CIC lays the foundation for its upcoming dedicated Phase I Unit, expanding its capabilities in early-phase and First-in-Human (FIH) clinical research.
PMCC Delegation:
Jennifer Li, Quality Manager, CCRU
Horace Wong, Assistant Manager, BRAS Drug Development Program
Anthony Msan, Clinical Study & Regulatory Specialist II
Key Highlights:
✔️ Strategic exchange on early-phase clinical trial development
✔️ Insightful discussions on operational models and quality frameworks
✔️ Strengthening institutional collaboration and global connectivity
✔️ Shared commitment to advancing oncology research excellence
The visit reinforced CIC’s drive toward research innovation and international best practices. We extend our sincere thanks to PMCC for their valuable insights and to CRM for their seamless coordination.
Together, we move closer to transforming the landscape of clinical research in Malaysia and beyond.
Read more: https://clinicalinvestigationcentre.com/2025/08/07/pmcc-delegation-visits-cic-ummc-amid-efforts-to-develop-phase-i-unit/
